United Therapeutics | UTHR - Fremdkapital





Fremdkapital Veränderung Datum
Ardelyx USD 203.52M 683K 2026-03
Baxter International USD 8.62B 6M 2026-06
Bayer EUR 31.16B 480M 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Insmed USD 543.51M 1.3M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
J&J USD 37.34B 183M 2026-06
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Moderna USD 597M 6M 2026-06
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 60.5B 70M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12